BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Vidal M, Chan DW, Gerstein M, Mann M, Omenn GS, Tagle D, Sechi S; Workshop Participants. The human proteome - a scientific opportunity for transforming diagnostics, therapeutics, and healthcare. Clin Proteomics 2012;9:6. [PMID: 22583803 DOI: 10.1186/1559-0275-9-6] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Mccomb S, Thiriot A, Krishnan L, Stark F. Introduction to the Immune System. In: Fulton KM, Twine SM, editors. Immunoproteomics. Totowa: Humana Press; 2013. pp. 1-20. [DOI: 10.1007/978-1-62703-589-7_1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
2 Meisner M, Reif DM. Computational Methods Used in Systems Biology. Systems Biology in Toxicology and Environmental Health. Elsevier; 2015. pp. 85-115. [DOI: 10.1016/b978-0-12-801564-3.00005-5] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
3 Nyman TA, Lorey MB, Cypryk W, Matikainen S. Mass spectrometry-based proteomic exploration of the human immune system: focus on the inflammasome, global protein secretion, and T cells. Expert Rev Proteomics 2017;14:395-407. [PMID: 28406322 DOI: 10.1080/14789450.2017.1319768] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
4 Bradshaw RA, Hondermarck H, Rodriguez H. Cancer Proteomics and the Elusive Diagnostic Biomarkers. Proteomics 2019;19:e1800445. [PMID: 31172665 DOI: 10.1002/pmic.201800445] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
5 Pan H, Ding H, Fang M, Yu B, Cheng Y, Tan Y, Fu Q, Lu B, Cai H, Jin X, Xia X, Zhang T. Proteomics and bioinformatics analysis of altered protein expression in the placental villous tissue from early recurrent miscarriage patients. Placenta 2018;61:1-10. [DOI: 10.1016/j.placenta.2017.11.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
6 Syed-Abdul S, Moldovan M, Nguyen PA, Enikeev R, Jian WS, Iqbal U, Hsu MH, Li YC. Profiling phenome-wide associations: a population-based observational study. J Am Med Inform Assoc 2015;22:896-9. [PMID: 25656518 DOI: 10.1093/jamia/ocu019] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
7 Kitchen RR, Rozowsky JS, Gerstein MB, Nairn AC. Decoding neuroproteomics: integrating the genome, translatome and functional anatomy. Nat Neurosci 2014;17:1491-9. [PMID: 25349915 DOI: 10.1038/nn.3829] [Cited by in Crossref: 42] [Cited by in F6Publishing: 32] [Article Influence: 5.3] [Reference Citation Analysis]
8 Iqbal U, Hsu C, Nguyen PA(, Clinciu DL, Lu R, Syed-abdul S, Yang H, Wang Y, Huang C, Huang C, Chang Y, Hsu M, Jian W, Li Y(. Cancer-disease associations: A visualization and animation through medical big data. Computer Methods and Programs in Biomedicine 2016;127:44-51. [DOI: 10.1016/j.cmpb.2016.01.009] [Cited by in Crossref: 24] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
9 Hood LE, Omenn GS, Moritz RL, Aebersold R, Yamamoto KR, Amos M, Hunter-Cevera J, Locascio L; Workshop Participants. New and improved proteomics technologies for understanding complex biological systems: addressing a grand challenge in the life sciences. Proteomics 2012;12:2773-83. [PMID: 22807061 DOI: 10.1002/pmic.201270086] [Cited by in Crossref: 47] [Cited by in F6Publishing: 40] [Article Influence: 5.2] [Reference Citation Analysis]
10 Xiong YM, Pan HT, Ding HG, He Y, Zhang J, Zhang F, Yu B, Zhang T, Huang HF. Proteomic and functional analysis of proteins related to embryonic development of decidua in patients with recurrent pregnancy loss. Biol Reprod 2021:ioab140. [PMID: 34296254 DOI: 10.1093/biolre/ioab140] [Reference Citation Analysis]
11 Kočevar N, Hudler P, Komel R. The progress of proteomic approaches in searching for cancer biomarkers. New Biotechnology 2013;30:319-26. [DOI: 10.1016/j.nbt.2012.11.011] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
12 Boja ES, Kinsinger CR, Rodriguez H, Srinivas P. Integration of omics sciences to advance biology and medicine. Clin Proteom 2014;11. [DOI: 10.1186/1559-0275-11-45] [Cited by in Crossref: 19] [Cited by in F6Publishing: 8] [Article Influence: 2.4] [Reference Citation Analysis]
13 Omenn GS. Plasma proteomics, the Human Proteome Project, and cancer-associated alternative splice variant proteins. Biochim Biophys Acta 2014;1844:866-73. [PMID: 24211518 DOI: 10.1016/j.bbapap.2013.10.016] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
14 Eid C, Palko JW, Katilius E, Santiago JG. Rapid Slow Off-Rate Modified Aptamer (SOMAmer)-Based Detection of C-Reactive Protein Using Isotachophoresis and an Ionic Spacer. Anal Chem 2015;87:6736-43. [PMID: 26024067 DOI: 10.1021/acs.analchem.5b00886] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 3.4] [Reference Citation Analysis]
15 Tonry CL, Doherty D, O’shea C, Morrissey B, Staunton L, Flatley B, Shannon A, Armstrong J, Pennington SR. Discovery and Longitudinal Evaluation of Candidate Protein Biomarkers for Disease Recurrence in Prostate Cancer. J Proteome Res 2015;14:2769-83. [DOI: 10.1021/acs.jproteome.5b00041] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
16 Aebersold R, Bader GD, Edwards AM, van Eyk JE, Kussmann M, Qin J, Omenn GS. The biology/disease-driven human proteome project (B/D-HPP): enabling protein research for the life sciences community. J Proteome Res 2013;12:23-7. [PMID: 23259511 DOI: 10.1021/pr301151m] [Cited by in Crossref: 86] [Cited by in F6Publishing: 77] [Article Influence: 8.6] [Reference Citation Analysis]
17 Omenn GS, Menon R, Zhang Y. Innovations in proteomic profiling of cancers: alternative splice variants as a new class of cancer biomarker candidates and bridging of proteomics with structural biology. J Proteomics 2013;90:28-37. [PMID: 23603631 DOI: 10.1016/j.jprot.2013.04.007] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 3.1] [Reference Citation Analysis]
18 Slany A, Bileck A, Muqaku B, Gerner C. Targeting breast cancer-associated fibroblasts to improve anti-cancer therapy. Breast 2015;24:532-8. [PMID: 26210685 DOI: 10.1016/j.breast.2015.06.009] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
19 Omenn GS. The strategy, organization, and progress of the HUPO Human Proteome Project. J Proteomics 2014;100:3-7. [PMID: 24145142 DOI: 10.1016/j.jprot.2013.10.012] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 3.7] [Reference Citation Analysis]
20 Skates SJ, Gillette MA, LaBaer J, Carr SA, Anderson L, Liebler DC, Ransohoff D, Rifai N, Kondratovich M, Težak Ž, Mansfield E, Oberg AL, Wright I, Barnes G, Gail M, Mesri M, Kinsinger CR, Rodriguez H, Boja ES. Statistical design for biospecimen cohort size in proteomics-based biomarker discovery and verification studies. J Proteome Res 2013;12:5383-94. [PMID: 24063748 DOI: 10.1021/pr400132j] [Cited by in Crossref: 79] [Cited by in F6Publishing: 78] [Article Influence: 8.8] [Reference Citation Analysis]
21 Groen AJ, Sancho-Andrés G, Breckels LM, Gatto L, Aniento F, Lilley KS. Identification of trans-golgi network proteins in Arabidopsis thaliana root tissue. J Proteome Res 2014;13:763-76. [PMID: 24344820 DOI: 10.1021/pr4008464] [Cited by in Crossref: 43] [Cited by in F6Publishing: 44] [Article Influence: 5.4] [Reference Citation Analysis]
22 Li XJ, Pan HT, Chen JJ, Fu YB, Fang M, He GH, Zhang T, Ding HG, Yu B, Cheng Y, Tan YJ, Zhao FL, Morse AN, Huang HF. Proteomics of Uterosacral Ligament Connective Tissue from Women with and without Pelvic Organ Prolapse. Proteomics Clin Appl 2019;13:e1800086. [PMID: 30516354 DOI: 10.1002/prca.201800086] [Reference Citation Analysis]
23 Vaudel M, Sickmann A, Martens L. Introduction to opportunities and pitfalls in functional mass spectrometry based proteomics. Biochim Biophys Acta 2014;1844:12-20. [PMID: 23845992 DOI: 10.1016/j.bbapap.2013.06.019] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 2.6] [Reference Citation Analysis]
24 Hühmer AFR, Paulus A, Martin LB, Millis K, Agreste T, Saba J, Lill JR, Fischer SM, Dracup W, Lavery P. The Chromosome-Centric Human Proteome Project: A Call to Action. J Proteome Res 2013;12:28-32. [DOI: 10.1021/pr300933p] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
25 Ni X, Li X, Guo Y, Zhou T, Guo X, Zhao C, Lin M, Zhou Z, Shen R, Guo X, Ling X, Huo R. Quantitative proteomics analysis of altered protein expression in the placental villous tissue of early pregnancy loss using isobaric tandem mass tags. Biomed Res Int 2014;2014:647143. [PMID: 24738066 DOI: 10.1155/2014/647143] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
26 Lawrence RT, Perez EM, Hernández D, Miller CP, Haas KM, Irie HY, Lee SI, Blau CA, Villén J. The proteomic landscape of triple-negative breast cancer. Cell Rep 2015;11:630-44. [PMID: 25892236 DOI: 10.1016/j.celrep.2015.03.050] [Cited by in Crossref: 124] [Cited by in F6Publishing: 105] [Article Influence: 17.7] [Reference Citation Analysis]
27 Murray E, Hernychová L, Scigelova M, Ho J, Nekulova M, O’neill JR, Nenutil R, Vesely K, Dundas SR, Dhaliwal C, Henderson H, Hayward RL, Salter DM, Vojtěšek B, Hupp TR. Quantitative Proteomic Profiling of Pleomorphic Human Sarcoma Identifies CLIC1 as a Dominant Pro-Oncogenic Receptor Expressed in Diverse Sarcoma Types. J Proteome Res 2014;13:2543-59. [DOI: 10.1021/pr4010713] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
28 Mccomb S, Thiriot A, Akache B, Krishnan L, Stark F. Introduction to the Immune System. In: Fulton KM, Twine SM, editors. Immunoproteomics. New York: Springer; 2019. pp. 1-24. [DOI: 10.1007/978-1-4939-9597-4_1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
29 McArdle A, Qasim Butt A, Szentpetery A, de Jager W, de Roock S, FitzGerald O, Pennington SR. Developing clinically relevant biomarkers in inflammatory arthritis: A multiplatform approach for serum candidate protein discovery. Proteomics Clin Appl 2016;10:691-8. [PMID: 26332844 DOI: 10.1002/prca.201500046] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
30 Füzéry AK, Levin J, Chan MM, Chan DW. Translation of proteomic biomarkers into FDA approved cancer diagnostics: issues and challenges. Clin Proteomics 2013;10:13. [PMID: 24088261 DOI: 10.1186/1559-0275-10-13] [Cited by in Crossref: 244] [Cited by in F6Publishing: 200] [Article Influence: 27.1] [Reference Citation Analysis]